REM sleep diversity following the pedunculopontine tegmental nucleus lesion in rat

Behavioural Brain Research

Volumn 271, Issue , 2014, Pages 258-268

  Petrovic, Jelena ^a   Lazic, Katarina ^a   Kalauzi, Aleksandar ^b   Saponjic, Jasna ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Cortico muscular coherence; EEG; EMG; Excitotoxic lesion; REM sleep; The pedunculopontine tegmental nucleus

Indexed keywords

IBOTENIC ACID; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE; AMINO ACID RECEPTOR STIMULATING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA RHYTHM; BRAIN DAMAGE; CONTROLLED STUDY; CORTICOMUSCULAR COHERENCE; DRIVE; ELECTROENCEPHALOGRAM; ELECTROMYOGRAPHY; FOURIER ANALYSIS; HISTOCHEMISTRY; MALE; NECK MUSCLE; NONHUMAN; NONREM SLEEP; PEDUNCULOPONTINE TEGMENTAL NUCLEUS; PRIORITY JOURNAL; RAT; REM SLEEP; SENSORIMOTOR CORTEX; SLEEP WAKING CYCLE; THETA RHYTHM; WAKEFULNESS; ANIMAL; BRAIN CORTEX; DRUG EFFECTS; ELECTROENCEPHALOGRAPHY; MICROINJECTION; PATHOLOGY; PATHOPHYSIOLOGY; WISTAR RAT;

ANIMALS; CEREBRAL CORTEX; ELECTROENCEPHALOGRAPHY; EXCITATORY AMINO ACID AGONISTS; IBOTENIC ACID; MALE; MICROINJECTIONS; PEDUNCULOPONTINE TEGMENTAL NUCLEUS; RATS; RATS, WISTAR; SLEEP, REM; WAKEFULNESS;

EID: 84903631282     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2014.06.026     Document Type: Article

References (57)

1. Postuma R.B., Gagnon J.F., Montplaisir J.Y. REM sleep behavior disorder: from dreams to neurodegeneration. Neurobiol Dis 2012, 46:553-558.
2. Boeve B.F., Silber M.H., Saper C.B., Ferman T.J., Dickson D.W., Parisi J.E., et al. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain 2007, 30:2770-2788.
3. Luppi P.H., Clement O., Sapin E., Gervasoni D., Peyron C., Leger L., et al. The neuronal network responsible for paradoxical sleep and its dysfunctions causing narcolepsy and rapid eye movement (REM) behavior disorder. Sleep Med Rev 2011, 15:153-163.
4. Sapin E., Lapray D., Berod A., Goutagny R., Leger L., Ravassard P., et al. Localization of the brainstem GABAergic neurons controlling paradoxical (REM) sleep. PLoS ONE 2009, 4:e4272.
5. Boeve B.F. Idiopathic REM sleep behavior disorder in the development of Parkinson's disease. Lancet Neurol 2013, 12:469-482.
6. Iranzo A., Molinuevo J.L., Santamaría J., Serradell M., Martí M.J., Valldeoriola F., et al. Rapid-eye-movement sleep behaviour disorder as an early marker for neurodegenerative disorder: a descriptive study. Lancet Neurol 2006, 5:572-577.
7. Iranzo A., Tolosa E., Gelpi E., Molinuevo J.L., Valldeoriola F., Serradell M., et al. Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study. Lancet Neurol 2013, 12:443-453.
8. Peever J., Luppi P.H., Montplaisir J. Breakdown in REM sleep circuitry underlies REM sleep behavior disorder. Trends Neurosci 2014, 37:279-288.
9. Lu J., Sherman D., Devor M., Saper C.B. A putative flip-flop switch for control of REM sleep. Nature 2006, 441:589-594.
10. Datta S., MacLean R.R. Neurobiological mechanisms for the regulation of mammalian sleep-wake behavior: reinterpretation of historical evidence and inclusion of contemporary cellular and molecular evidence. Neurosci Biobehav Rev 2007, 31:775-824.
11. Takakusaki K., Habaguchi T., Saitoh K., Kohyama J. Changes in the excitability of hindlimb motoneurons during muscular atonia induced by stimulating the pedunculopontine tegmental nucleus in cats. Neuroscience 2004, 124:467-480.
12. Saponjic J., Radulovacki M., Carley D.W. Respiratory pattern modulation by the pedunculopontine tegmental nucleus. Respir Physiol Neurobiol 2003, 138:223-237.
13. Saponjic J., Cvorovic J., Radulovacki M., Carley D.W. Serotonin and noradrenaline modulate respiratory pattern disturbance evoked by glutamate injection into the pedunculopontine tegmentum of anesthetized rats. Sleep 2005, 28:560-570.
14. Saponjic J., Radulovacki M., Carley D.W. Injection of glutamate into the pedunculopontine tegmental nuclei of anesthetized rat causes respiratory dysrhythmia and alters EEG and EMG power. Sleep Breath 2005, 9:82-91.
15. Saponjic J., Radulovacki M., Carley D.W. Modulation of respiratory pattern and upper airway muscle activity by the pedunculopontine tegmentum: role of NMDA receptors. Sleep Breath 2006, 10:195-202.
16. Rye D.B. Contributions of the pedunculopontine region to normal and altered REM sleep. Sleep 1997, 20:757-788.
17. Semba K. Aminergic and cholinergic afferents to REM sleep induction regions of the pontine reticular formation in the rat. J Comp Neurol 1993, 330:543-556.
18. Losier B.J., Semba K. Dual projections of single cholinergic and aminergic brainstem neurons to the thalamus and basal forebrain in the rat. Brain Res 1993, 604:41-52.
19. Dringenberg H.C., Olmstead M.C. Integrated contributions of basal forebrain and thalamus to neocortical activation elicited by pedunculopontine tegmental stimulation in urethane-anesthetized rats. Neuroscience 2003, 119:839-853.
20. Sarter M., Bruno J.P. Cortical cholinergic inputs mediating arousal, attentional processing and dreaming: differential afferent regulation of the basal forebrain by telencephalic and brainstem afferents. Neuroscience 2000, 95:933-952.
21. Pienaar I.S., Harrison I.F., Elson J.L., Bury A., Woll P., Simon A.K., et al. An animal model mimicking pedunculopontine nucleus cholinergic degeneration in Parkinson's disease. Brain Struct Funct 2014, 10.1007/s00429-013-0669-5.
22. Kotagal V., Albin R.L., Müller M.L.T.M., Koeppe R.A., Chervin R.D., Frey K.A., et al. Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease. Ann Neurol 2012, 71:560-568.
23. Kotagal V., Müller M.L.T.M., Kaufer D.I., Koeppe R.A., Bohnen N.I. Thalamic cholinergic innervation is spared in Alzheimer disease compared to Parkinsonian disorders. Neurosci Lett 2012, 514:169-172.
24. Bohnen N.I., Albin R.L. The cholinergic system and Parkinson disease. Behav Brain Res 2011, 221:564-573.
25. Bohnen N.I., Müller M.L.T.M., Koeppe R.A., Studenski S.A., Kilbourn M.A., Fey K.A., et al. History of falls in Parkinson disease is associated with reduced cholinergic activity. Neurology 2009, 73:1670-1676.
26. Bezard E., Przedborski S. A tale on animal model of Parkinson's disease. Mov Disord 2011, 26:993-1002.
27. Balandini F., Armentero M.T., Martignoni E. The 6-hydroxydopamine model: news from the past. Parkinsonism Relat Disord 2008, 14(Suppl. 2):S124-S129.
28. Baladini F., Armentero M.T. Animal models of Parkinson's disease. FEBS J 2012, 279:1156-1166.
29. Duty S., Jenner P. Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease. Br J Pharmacol 2011, 164:1357-1391.
30. Pineaar I.S., van de Berg W. A non-cholinergic neuronal loss in the pedunculopontine nucleus of toxin-evoked parkinsonian rats. Exp Neurol 2013, 248:213-223.
31. Petrovic J., Lazic K., Ciric J., Kalauzi A., Saponjic J. Topography of the sleep/wake states related EEG microstructure and transitions structure differentiates the functionally distinct cholinergic innervation disorders in rat. Behav Brain Res 2013, 256:108-118.
32. Saponjic J., Petrovic J., Kalauzi A., Ciric J., Lazic K., Radulovacki M., et al. Sleep-state related EEG amplitude distribution in the rat model of cortical cholinergic innervation disorder. Sleep Biol Rhythm 2013, 11:105-115.
33. Petrovic J., Ciric J., Lazic K., Kalauzi A., Saponjic J. Lesion of the pedunculopontine tegmental nucleus in rat augments cortical activation and disturbs sleep/wake state transitions structure. Exp Neurol 2013, 247:562-571.
34. Saponjic J., Radulovacki M., Carley D.W. Monoaminergic system lesions increase post-sigh respiratory pattern disturbance during sleep in rats. Physiol Behav 2007, 90:1-10.
35. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 2005, Elsevier Academic Press, San Diego, USA. 5th ed.
36. Inglis W.L., Semba K. Discriminable excitotoxic effects of ibotenic acid, AMPA, NMDA and quinolinic acid in the rat laterodorsal tegmental nucleus. Brain Res 1997, 755:17-27.
37. Paxinos G., Watson C., Carrive P., Kirkcaldie M., Ashwell K.W.S. Chemoarchitectonic atlas of the rat brain 2009, Academic Press, London, UK. 2nd ed.
38. Yan M.M., Xu X.H., Huang Z.L., Yao M.H., Urade Y., Qu W.M. Selection of optimal epoch duration in assessment of rodent sleep-wake profiles. Sleep Biol Rhythm 2011, 9:46-55.
39. Jung K.Y., Cho J.H., Ko D., Seok H.Y., Yoon H.K., Lee H.J., et al. Increased corticomuscular coherence in idiopathic REM sleep behavioral disorder. Front Neurol 2012, 3:1-6.
40. Ushiyama J., Takahashi Y., Ushiba J. Muscle dependency of corticomuscular coherence in upper and lower limb muscles and training-related alterations in ballet dancers and weightlifters. J Appl Physiol 2010, 109:1086-1095.
41. Kamp D., Krause V., Butz M., Schnitzler A., Pollok B. Changes of cortico-muscular coherence: an early marker of healthy aging. Age 2013, 35:49-58.
42. Krause V., Wach C., Sudmeyer M., Ferrea S., Schnitzler A., Pollok B. Cortico-muscular coupling and motor performance are modulated by 20Hz transcranial alternating current stimulation (tACS) in Parkinson's disease. Front Hum Neurosci 2014, 7:1-10.
43. Kristeva R., Patino L., Omlor W. Beta-range cortical motor spectral power and corticomuscular coherence as a mechanism for effective corticospinal interaction during steady-state motor output. NeuroImage 2007, 36:785-792.
44. Salenius S., Avikainen S., Kaakkola S., Hari R., Brown P. Defective cortical drive to muscle in Parkinson's disease and its improvement with levodopa. Brain 2002, 125:491-500.
45. Moroni F., Nobili L., De Carli F., Massimini M., Francione S., Marzano C., et al. Slow EEG rhythms and inter-hemispheric synchronization across sleep and wakefulness in the human hippocampus. NeuroImage 2012, 60:497-504.
46. Genzel L., Dresler M. Sleep-more local and complex than previously thought. Front Neurol 2012, 3:1-2.
47. Braak H., Del Tredici K., Rüb U., de Vos R.A., Jansen Steur E.N., Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003, 24:197-211.
48. Engel A.K., Fries P. Beta-band oscillations - signaling the status quo. Curr Opin Neurobiol 2010, 20:156-165.
49. Grace K.P., Hughes S.W., Horner R.L. Identification of the mechanism mediating genioglosus muscle suppression in REM sleep. Am J Respir Crit Care Med 2013, 187:311-319.
50. Torontali Z.A., Grace K.P., Horner R., Peever J.H. Cholinergic involvement in control of REM sleep paralysis. J Physiol 2014, 592:1425-1426.
51. Jenkinson N., Nandi D., Muthusamy K., Ray N.J., Gregory R., Stein J.F., et al. Anatomy, physiology, and pathophysiology of the pedunculopontine nucleus. Mov Disord 2009, 24:319-328.
52. Alam M., Schwabe K., Krauss J.K. The pedunculopontine nucleus area: critical evaluation of interspecies differences relevant for its use as a target for deep brain stimulation. Brain 2011, 134:11-23.
53. Futami T., Takakusaki K., Kitai S.T. Glutamatergic and cholinergic inputs from the pedunculopontine tegmental nucleus to dopamine neurons in the substantia nigra pars compacta. Neurosci Res 1995, 21:331-342.
54. Hur E.E., Zaborszky L. Vglut2 afferents to the medial prefrontal and primary somatosensory cortices: a combined retrograde tracing in situ hybridization study. J Comp Neurol 2005, 483:351-373.
55. Kaur S., Junek A., Black M.A., Semba K. Effects of ibotenate and 192IgG-saporin lesions of the nucleus basalis magnocellularis/substantia innominata on spontaneous sleep and wake states and on recovery sleep after sleep deprivation in rats. J Neurosci 2008, 28:491-504.
56. Lavoie B., Parent A. Pedunculopontine nucleus in the squirrel monkey: distribution of cholinergic and monoaminergic neurons in the mesopontine tegmentum with evidence for the presence of glutamate in cholinergic neurons. J Comp Neurol 1994, 344:190-209.
57. Rugg E.L., Dunbar J.S., Latimer M., Winn P. Excitotoxic lesions of the pedunculopontine tegmental nucleus of the rat I. Comparison of the effects of various excitotoxins, with particular reference to the loss of immunohistochemically identified cholinergic neurons. Brain Res 1992, 589:181-193.